(Q34460643)

2 August 2017

1 reference

title

Autoimmune encephalitis and its relation to infection (English)

1 reference

2 August 2017

1 reference

Arun Venkatesan

1

1 reference

2 August 2017

David R Benavides

series ordinal

2

1 reference

2 August 2017

publication date

1 March 2015

1 reference

Current Neurology and Neuroscience Reports

2 August 2017

published in

1 reference

2 August 2017

volume

15

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

3

1 reference

Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

New estimates of incidence of encephalitis in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Beyond viruses: clinical profiles and etiologies associated with encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Infectious encephalitis in france in 2007: a national prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Paraneoplastic neurological syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Predictors of outcome in acute encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Diagnosis and management of acute encephalitis: A practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Criteria for environmentally associated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Molecular mechanisms of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

The anatomical and cellular basis of immune surveillance in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Autoimmune and inflammatory mechanisms of CNS damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Infections and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

21 January 2018

Natural autoantibodies.

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Infection of human endothelial cells by Japanese encephalitis virus: increased expression and release of soluble HLA-E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Virus-induced transcriptional changes in the brain include the differential expression of genes associated with interferon, apoptosis, interleukin 17 receptor A, and glutamate signaling as well as flavivirus-specific upregulation of tRNA synthetases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Genetics of autoimmune diseases--disorders of immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Herpes simplex encephalitis as a potential cause of anti-N-methyl-D-aspartate receptor antibody encephalitis: report of 2 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Viral triggering of anti-NMDA receptor encephalitis in a child - an important cause for disease relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Anti-N-methyl-D-aspartate receptor encephalitis that developed after herpes encephalitis: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Herpes simplex virus encephalitis is a trigger of brain autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Glutamatergic autoencephalitides: an emerging field

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Focal seizures due to chronic localized encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Autoimmunity to munc-18 in Rasmussen's encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Differential expression of interferon-γ and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Virus in brain of child with hemiplegia, hemiconvulsions, and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Herpesviruses in chronic encephalitis associated with intractable childhood epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the Vaccine Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0529-1

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

21 January 2018

1 reference

12 December 2020

Epstein-Barr virus in brain and Rasmussen's encephalitis

1 reference

12 December 2020

Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients

1 reference

12 December 2020

Regulatory T Cells Selectively Preserve Immune Privilege of Self-Antigens during Viral Central Nervous System Infection

1 reference

12 December 2020

The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America

1 reference

12 December 2020

Cytomegalovirus and Rasmussen's encephalitis

1 reference

12 December 2020

10.1007/S11910-015-0529-1

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1034906239

0 references

1 reference